- Rating
- 2
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper presents EVO-IF, a framework that integrates a pretrained genome language model with a structure-conditioned diffusion model for RNA and DNA inverse folding. A compact learned-query interface aligns genome-language representations with geometric residue states, while polymer-context conditioning enables sequence design in heterogeneous molecular assemblies. The authors report strong native-sequence recovery on the Das RNA benchmark and a 121-assembly DNA benchmark, together with improvements over a structure-only reference and faster inference using one-pass decoding.
Critical strengths
-
The paper addresses a meaningful gap between genome-scale sequence models and structure-conditioned nucleic-acid design. Connecting the two is a reasonable approach to improving design when experimentally determined sequence–structure pairs are limited.
-
The use of a frozen EVO 2-7B encoder and a trainable interface with approximately 1.18 million parameters is attractive. The learned-query mechanism compresses the genome-language representations before connecting them to geometric residue states. This offers a potentially parameter-efficient way to incorporate a large pretrained model without fully fine-tuning it.
Critical weaknesses
- The contribution of EVO 2 needs to be isolated more convincingly.
The main claim is that genome-language representations improve structure-conditioned sequence design. The reported comparison against a structure-only model supports this claim at the system level. However, it does not fully establish which information from EVO 2 is responsible for the improvement, or whether the benefit specifically depends on the pretrained genome representation rather than the additional adaptation and training procedure. The manuscript includes useful interventions, including disabling the genome–geometry bridge and permuting the input sequence. However, the reported fixed-weight interventions use an intermediate checkpoint, whereas the headline performance is reported for the released checkpoint. The relationship between these experiments and the final model should be further clarified.
- The comparison with existing methods should be more uniform.
The manuscript compares EVO-IF with several published approaches, including NA-MPNN, gRNAde, RBFN, and RhoDesign. However, the evaluation protocols are not entirely uniform: some baseline results are taken from prior publications, while others are reproduced under the authors' evaluation pipeline.
- The design of the genome–structure interface needs a more direct justification.
The architecture is plausible, but several choices appear to be empirical design decisions:
- The use of 16 learned queries to compress EVO 2 representations.
- The selection of the activation from a particular EVO 2 layer.
- The concatenation of nucleic-acid chains without separator tokens.
- The use of polymer-presence bits to select context-specific modulation.
The manuscript includes some relevant ablations, including the chain-serialization comparison. However, the evidence supporting the key interface choices remains limited.
- There appears to be an unresolved citation placeholder in the Introduction.
Questions for authors
-
Can the authors document the training–test separation and demonstrate that the principal results are not driven by close sequence or structural homologues of the evaluation targets?
-
Can the authors provide a matched comparison that isolates the contribution of the pretrained genome-language representation from the effects of the structural model, additional training, and curriculum adaptation?
-
Does the learned-query bottleneck preserve enough information for residue-level sequence design?
-
Beyond recovering the native sequence, how consistently do the designed sequences reproduce the target structure, particularly in the DNA and protein–nucleic-acid assembly evaluations?
-
Do the reported gains persist across independent training runs or checkpoints, and is the one-pass advantage specific to the selected checkpoint?
2 comments
Thank you for the detailed responses and additional experiments. The authors have addressed several concerns, but some important issues remain partially unresolved. In particular, the absence of close sequence or structural homologues in the evaluation sets has not been demonstrated, and the contribution of EVO 2 remains insufficiently isolated, given that the fixed-weight interventions use an intermediate rather than the released checkpoint. I therefore maintain my original score.
Thank you for distinguishing the system-level results from the evidence needed to explain them. We have additionally clarified the method, identified which comparisons use the released checkpoint.
The structural starting checkpoint, subsequent Evo-IF training, and frozen Evo2 pretraining are three separate sources of exposure. DNA-121 consists of 28 DNA-only, 78 protein–DNA, and 15 protein–DNA–RNA assemblies, with recovery measured only at DNA positions. Training data are fully isolated from any evaluations with zero overlap.
At inference, the initial Evo2 input is a backbone-predicted candidate, not the native sequence at designed positions.
The controlled self-consistency comparison in the current manuscript is between the reproduced NA-MPNN and Evo-IF. Their scMCC values are 0.450 and 0.564, scTM values are 0.409 and 0.487, and scRMSD values are 3.30 and 2.87 Å. The gRNAde and RBFN values from prior reports are historical references with same evaluation protocols. We have reinforced this distinction in the evaluation description and table caption, including the provenance of the reported dispersion.
We supplement comparisons which evaluate some methods on the same single-state test set and report recovery alongside self-consistency. RIDER and RiboPO are included with matched candidate counts and score aggregation. Published reference values will remain separate from shared-protocol reruns.
The 16 queries compress the genome memory. Every residue retains its own geometric state and attends to the shared memory with a different query. Schematically, before the output projection and normalization, the retrieved signal for residue (i) has the form
ui=∑k=116aikvk
where the weights (a_{ik}) depend on that residue's structural state. Sharing 16 memory vectors therefore does not force all residues to receive the same update or discard their local geometric information. We have made this distinction explicit.
A compact query-count sweep train the interface with (K=4,16,32), from the same frozen structural checkpoint and under the same data and update budget. The primary diagnostic is the change in recovery, also stratified by target length.
The 16-to-32 difference is trivial, including on longer targets, so that we believe 16 as a practical operating point under that budget.
For RNA, the reproduced self-consistency results provide evidence beyond recovery. For DNA and protein–nucleic-acid assemblies, the reported measurements establish native-sequence recovery under a fixed backbone and molecular context. They do not establish that the designed complex independently adopts that structure or preserves binding function. We have stated this limitation explicitly rather than extrapolating the RNA folding results to DNA assemblies.
Independent complex structure prediction or sequence-dependent relaxation would provide stronger evidence but is a separate, more expensive evaluation. Our main contribution is computational backbone-conditioned sequence design, with RNA predictor-based fold validation and a narrower recovery-based validation for DNA assemblies.
The one-pass advantage is currently established for the released checkpoint on the reported main benchmarks, but we see totally same trends on other checkpoints. The 30.7× latency ratio compares these two decoders of Evo-IF under the measured runtime setup.
We do not claim that iterative refinement is generally inferior. In the existing temporal continuation experiment, Iter-30 improves recovery by 2.03 points at the starting checkpoint. On the pseudoknot comparison, it improves median recovery from 56.2% to 57.9%. The revised abstract, method, and limitations therefore will clarify the one-pass claim to cleaner evaluation settings.